Vares Guillaume, Ahire Vidhula, Sunada Shigeaki, Ho Kim Eun, Sai Sei, Chevalier François, Romeo Paul-Henri, Yamamoto Tadashi, Nakajima Tetsuo, Saintigny Yannick
Cell Signal Unit, Okinawa Institute of Science and Technology Graduate University (OIST), Japan.
Research Laboratory and Open Facility for Radiation Biology with Accelerated Ions (LARIA), CEA/DRF/IBFJ/IRCM, Caen, France; Centre de Recherche sur les Ions, les Matériaux et la Photonique (CIMAP), Normandie Univ/ENSICAEN/UNICAEN/CEA/CNRS, Caen, France.
Radiother Oncol. 2020 Sep;150:253-261. doi: 10.1016/j.radonc.2020.07.034. Epub 2020 Jul 24.
High-grade chondrosarcomas are chemo- and radio-resistant cartilage-forming tumors of bone that often relapse and metastase. Thus, new therapeutic strategies are urgently needed.
Chondrosarcoma cells (CH-2879) were exposed to carbon-ion irradiation, combined with miR-34 mimic and/or rapamycin administration. The effects of treatment on cancer stem cells, stemness-associated phenotype, radioresistance and tumor-initiating properties were evaluated.
We show that high-grade chondrosarcoma cells contain a population of radioresistant cancer stem cells that can be targeted by a combination of carbon-ion therapy, miR-34 mimic administration and/or rapamycin treatment that triggers FOXO3 and miR-34 over-expression. mTOR inhibition by rapamycin triggered FOXO3 and miR-34, leading to KLF4 repression.
Our results show that particle therapy combined with molecular treatments effectively controls cancer stem cells and may overcome treatment resistance of high-grade chondrosarcoma.
高级别软骨肉瘤是骨的化疗和放疗抵抗性软骨形成肿瘤,常复发和转移。因此,迫切需要新的治疗策略。
将软骨肉瘤细胞(CH-2879)暴露于碳离子辐射,并联合给予miR-34模拟物和/或雷帕霉素。评估治疗对癌症干细胞、干性相关表型、放射抗性和肿瘤起始特性的影响。
我们发现高级别软骨肉瘤细胞包含一群放射抗性癌症干细胞,碳离子疗法、miR-34模拟物给药和/或雷帕霉素治疗联合可靶向这些细胞,该联合治疗可触发FOXO3和miR-34过表达。雷帕霉素抑制mTOR可触发FOXO3和miR-34,导致KLF4表达受抑制。
我们的结果表明,粒子疗法联合分子治疗可有效控制癌症干细胞,并可能克服高级别软骨肉瘤的治疗抵抗。